Access to anti-retroviral drugs, female in Ireland

Ireland: Access to anti-retroviral drugs, female was 90.0% in 2023. ▲ Rising

Latest (2023)
90.0%
Change on year
down 2.2%
World rank
27th
of 141 countries
All-time high
92.0%
in 2022
All-time low
47.0%
in 2000
Years of data
24
2000–2023

Access to anti-retroviral drugs, female in Ireland, 2000–2023

0204060801002000201120232000: 47 %2001: 53 %2002: 58 %2003: 62 %2004: 65 %2005: 67 %2006: 68 %2007: 69 %2008: 70 %2009: 72 %2010: 74 %2011: 75 %2012: 76 %2013: 77 %2014: 77 %2015: 75 %2016: 75 %2017: 75 %2018: 77 %2019: 82 %2020: 86 %2021: 87 %2022: 92 %2023: 90 %

Source: UNAIDS estimates. Measured in %.

Analysis

The most recent figure for access to anti-retroviral drugs, female in Ireland is 90.0%, measured in 2023.

The figure is down 2.2% on the previous year and up 16.9% over ten years.

Over the whole period, access to anti-retroviral drugs, female in Ireland peaked at 92.0% in 2022 and was at its lowest, 47.0%, in 2000.

Ireland ranks 27th of 141 countries on this measure, in the top quarter.

The long-run direction has been consistently rising across the 24 years of available data.

Access to anti-retroviral drugs, female in Ireland, year by year

Annual values for Access to anti-retroviral drugs, female (%) in Ireland, 2000 to 2023.
Year % Change
2000 47.0%
2001 53.0% +12.8%
2002 58.0% +9.4%
2003 62.0% +6.9%
2004 65.0% +4.8%
2005 67.0% +3.1%
2006 68.0% +1.5%
2007 69.0% +1.5%
2008 70.0% +1.4%
2009 72.0% +2.9%
2010 74.0% +2.8%
2011 75.0% +1.4%
2012 76.0% +1.3%
2013 77.0% +1.3%
2014 77.0% +0.0%
2015 75.0% -2.6%
2016 75.0% +0.0%
2017 75.0% +0.0%
2018 77.0% +2.7%
2019 82.0% +6.5%
2020 86.0% +4.9%
2021 87.0% +1.2%
2022 92.0% +5.7%
2023 90.0% -2.2%

Averages by decade

DecadeAverage LowestHighest Years
2000s 63.1% 47.0% 72.0% 10
2010s 76.3% 74.0% 82.0% 10
2020s 88.8% 86.0% 92.0% 4

Countries ranked near Ireland

  1. 25 Denmark 91.0% compare
  2. 25 Saudi Arabia 91.0% compare
  3. 27 Ethiopia 90.0% compare
  4. 27 Haiti 90.0% compare
  5. 27 Kenya 90.0% compare
  6. 27 Romania 90.0% compare
  7. 27 Switzerland 90.0% compare
  8. 27 Tanzania, United Republic of 90.0% compare
  9. 27 Thailand 90.0% compare

See the full ranking of 160 places →

More gender data for Ireland

All data for Ireland →

Frequently asked questions

What is access to anti-retroviral drugs, female in Ireland?
Access to anti-retroviral drugs, female in Ireland was 90.0% in 2023, according to UNAIDS estimates.
What is the highest access to anti-retroviral drugs, female recorded in Ireland?
The highest recorded value was 92.0% in 2022.
What is the lowest access to anti-retroviral drugs, female recorded in Ireland?
The lowest recorded value was 47.0% in 2000.
How does Ireland rank for access to anti-retroviral drugs, female?
Ireland ranks 27th out of 141 countries with data for 2023.
Is access to anti-retroviral drugs, female rising or falling in Ireland?
Over the last ten years it is up 16.9%. The long-run trend across the full record is rising.
Where does this Ireland data come from?
The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, female (%). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 24 observations, free to reuse under CC BY 4.0 (World Bank Open Data).

Share, cite or embed this page

Cite this page

Access to anti-retroviral drugs, female in Ireland. Statizoid, drawing on UNAIDS estimates. Retrieved 10 September 2026, from https://gender.statizoid.com/stat/access-to-anti-retroviral-drugs-female-percent/ireland/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://gender.statizoid.com/stat/access-to-anti-retroviral-drugs-female-percent/ireland/">Access to anti-retroviral drugs, female in Ireland</a> — Statizoid

About this data

Indicator
Access to anti-retroviral drugs, female (%)
Unit
%
Source
UNAIDS estimates
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
160 places, 3,925 data points, 2000–2024
Last refreshed

The percentage of adult females living with HIV who are receiving antiretroviral therapy.